Publications by authors named "Sandra Tong"

Claim this Profile
N
NGLY1 deficiency: a prospective natural history study.
Sandra Tong, Pamela Ventola, Christina H Frater, Jenna Klotz, Jennifer M Phillips

Hum Mol Genet· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NGLY1 deficiency: estimated incidence, clinical features, and genotypic spectrum from the NGLY1 Registry.
Caroline R Stanclift, Selina S Dwight, Kevin Lee, Quirine L Eijkenboom, Matt Wilsey, Sandra Tong

Orphanet J Rare Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.
David J Kuter, Kerry A Rogers, Michael A Boxer, Michael Choi, Richy Agajanian, Sandra Tong

Am J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia.
Ralph Boccia, Nichola Cooper, Waleed Ghanima, Michael A Boxer, Quentin A Hill, Sandra Tong

Br J Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program.
James B Bussel, Donald M Arnold, Michael A Boxer, Nichola Cooper, Jiri Mayer, Sandra Tong

Am J Hematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS).
Heather L Gelhorn, Xin Ye, Rebecca M Speck, Sandra Tong, John H Healey

J Patient Rep Outcomes· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
Heather L Gelhorn, Sandra Tong, Kelly McQuarrie, Christina Vernon, Jennifer Hanlon

Clin Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel p38α mitogen-activated protein kinase inhibitor shows analgesic efficacy in acute postsurgical dental pain.
Sandra E Tong, Stephen E Daniels, Peter Black, Stephen Chang, Andrew Protter

J Clin Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis.
Mark C Genovese, Stanley B Cohen, David Wofsy, Michael E Weinblatt, Gary S Firestein, Sandra E Tong

J Rheumatol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis